Pharmacokinetic Determinants of Virological Response to Raltegravir in the In Vitro Pharmacodynamic Hollow-Fiber Infection Model System

av Brown, Ashley N., Adams, Jonathan R., Baluya, Dodge L., Drusano, George L.
I publikationen Antimicrob Agents Chemother (2015)

Zanamivir, at 600 Milligrams Twice Daily, Inhibits Oseltamivir-Resistant 2009 Pandemic H1N1 Influenza Virus in an In Vitro Hollow-Fiber Infection Model System

av Brown, Ashley N., McSharry, James J., Weng, Qingmei, Adams, Jonathan R., Kulawy, Robert, Drusano, George L.
Publicerad 2011

Oseltamivir-Zanamivir Combination Therapy Suppresses Drug-Resistant H1N1 Influenza A viruses in the Hollow Fiber Infection Model (HFIM) System

av Pires de Mello, Camilly P., Drusano, George L., Adams, Jonathan R., Shudt, Matthew, Kulawy, Robert, Brown, Ashley N.
I publikationen Eur J Pharm Sci (2017)

Effect of Half-Life on the Pharmacodynamic Index of Zanamivir against Influenza Virus Delineated by a Mathematical Model

av Brown, Ashley N., Bulitta, Jürgen B., McSharry, James J., Weng, Qingmei, Adams, Jonathan R., Kulawy, Robert, Drusano, George L.
Publicerad 2011

Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

av Brown, Ashley N., McSharry, James J., Adams, Jonathan R., Kulawy, Robert, Barnard, Richard J. O., Newhard, W., Corbin, A., Hazuda, Daria J., Louie, Arnold, Drusano, George L.
Publicerad 2012

Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy

av Brown, Ashley N., Drusano, George L., Adams, Jonathan R., Rodriquez, Jaime L., Jambunathan, Kalyani, Baluya, Dodge L., Brown, David L., Kwara, Awewura, Mirsalis, Jon C., Hafner, Richard, Louie, Arnold
I publikationen mBio (2015)